Celltrion
068270.KS
#934
Rank
C$37.01 B
Marketcap
C$161.41
Share price
0.06%
Change (1 day)
-1.02%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): C$2.64

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$2.66. an increase over its 2024 EPS that were of C$1.73.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025C$4.56163.66%
2024C$1.73-53.73%
2023C$3.74-2.08%
2022C$3.82-11.72%
2021C$4.332.03%
2020C$4.2482.8%
2019C$2.3218.31%
2018C$1.96-36.33%
2017C$3.08161.25%
2016C$1.182.86%
2015C$1.1517.84%
2014C$0.975.87%
2013C$0.92-70.85%
2012C$3.15134.09%
2011C$1.3543.59%
2010C$0.9474.49%
2009C$0.54317.8%
2008C$0.13-71.7%
2007C$0.45